Bioceres Crop Solutions Corp (BIOX)

$BIOX: Now at $0.38... also a Nano-ag

Makes more money than $NXTS and lower MarketCap than it today........ but look at $NXTS flying.

This one is due for a Mega move.

Loading 10k here at $0.38

LFG !!!!!!!!!


GO $BIOX

Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational ResultsMay 11, 2026 5:00 PM
Business Wire Total revenues in 3Q26 were $39.4 million 3Q26 net loss was $10.0 million and Adjusted EBITDA1 was $(0.6) million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2026. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Presentation of Results In January 2026, the Company’s Pro Farm Group (PFG) business was subject to a foreclosure auction and has been classified as discontinued operations. Accordingly, unless otherwise indicated, the financial results discussed below reflect the Company’s continuing operations for all periods presented, and prior-year amounts have been recast to exclude the PFG business. Financial & Business Highlights Total revenues were $39.4 million in 3Q26, a 23% year-over-year decline, reflecting softer demand and competitive pressures in Crop Protection, together with the ongoing transition in Seeds. Crop Nutrition revenues increased 15% during the quarter. Gross profit was $12.7 million, with gross margin of 32%, reflecting lower revenues and product mix effects across segments. Crop Nutrition results were impacted by a non-recurring obsolescence adjustment in inoculants related to inventory normalization efforts. SG&A expenses declined 16% year over year, reflecting continued execution of organizational streamlining and cost management initiatives across the continuing operations. Net loss was $10.0 million and Adjusted EBITDA1 was $(0.6) million, primarily reflecting lower gross profit and the absence of prior-year non-cash income associated with the reorganization in Seeds. Following the Pro Farm foreclosure auction earlier this year, and the related noteholder dispute, the Company continued advancing liability management initiatives across its operating subsidiaries, including debt reprofiling efforts and a voluntary bond maturity extension process in Argentina. Management Review Mr. Federico Trucco, Bioceres’ Chief Executive Officer, commented: “This quarter reflects a period of transition and operational refocusing for the Company. While market conditions in several areas of our business remain challenging, and the effects of the transition in Seeds continue to weigh on reported results, we are increasingly focused on strengthening the fundamentals of the organization and prioritizing disciplined execution across the platform. “During the quarter, we continued advancing initiatives aimed at simplifying the organization, improving operational efficiency, strengthening working capital management and improving cash generation and liability management across key operating subsidiaries. In parallel, we are reinforcing governance and internal processes and conducting a strategic review of our continuing operations — including initiatives focused on organizational streamlining and capital allocation optimization — to ensure that capital, management attention, and resources remain aligned with the areas where we believe we can create the greatest long-term value. “We recognize the significance of the events surrounding Pro Farm and the uncertainty generated by the ongoing litigation process. While we continue to pursue the appropriate legal course and evaluate constructive alternatives where possible, our priority remains clear: stabilizing the business, preserving the value of our core operations, and positioning the Company for a more resilient and sustainable future.”   Key Financial Metrics
Table 1: 3Q26 Key Financial Metrics    (In millions of U.S. dollars) 3Q25 3Q26 %CHANGE Revenue by Segment       Crop Protection 30.1 24.6 -18% Seed and Integrated Products 10.9 3.2 -71% Crop Nutrition 10.1 11.6 15% Total Revenue 51.1 39.4 -23% Gross Profit 18.1 12.7 -30% Gross Margin 35% 32% -310 bpts   3Q25 3Q26 %CHANGE GAAP Net income or loss 2.3 (10.0) -528% Adjusted EBITDA1 9.1 (0.6) -107%   3Q26 Summary: Revenue performance in the third quarter reflects mixed demand dynamics across segments, particularly in Crop Protection, together with the ongoing transition in Seeds toward a more asset-light model. While these factors weighed on reported revenues, Crop Nutrition continued to grow, driven by microbeaded fertilizers. Gross profit and margins declined year over year, reflecting lower revenues, product mix effects, and the impact of a non-recurring obsolescence adjustment in inoculants, associated with inventory normalization efforts during the period. At the same time, the Company continued to execute on cost management and working capital initiatives, resulting in meaningful reductions in operating expenses and improvements in cash conversion dynamics during the quarter. Profitability metrics were additionally impacted by the absence of prior year non-cash income associated with changes in contractual obligations and intellectual property arrangements as part of the reorganization in Seeds, which affected year-over-year comparability. For a full version of Bioceres’ third quarter 2026 earnings release, click here
Fiscal Third Quarter 2026 Earnings Conference Call Management will host a conference call and question-and-answer session, which will be accompanied by a presentation available during the webcast or accessed via the investor relations section of the company’s website. To access the call, please use the following information:   Date: Wednesday, May 12, 2026       Time: 8:30 a.m. EST, 5:30 a.m. PST   Please dial in 5-10 minutes prior to the start time to register and join. The conference call will be broadcast live and available for replay here and via the investor relations section of the company’s website here.   US Toll Free dial-in number: 1-833-461-5787     International dial-in numbers: Click here       Conference ID: 717574163       Webcast: Click here       About Bioceres Crop Solutions Corp. Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. The company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation Crop Nutrition and Protection solutions. For more information, visit here. Forward-Looking Statements This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include estimated financial data, and any such forward-looking statements involve risks, assumptions and uncertainties. These forward-looking statements include, but are not limited to, whether (i) the health and safety measures implemented to safeguard employees and assure business continuity will be successful and (ii) we will be able to coordinate efforts to ramp up inventories. Such forward-looking statements are based on management’s reasonable current assumptions, expectations, plans and forecasts regarding the company’s current or future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or achievement of the company to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management’s expectations or could affect the company’s ability to achieve its strategic goals, including the uncertainties relating to the other factors that are described in the sections entitled “Risk Factors” in the company's Securities and Exchange Commission filings updated from time to time. The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. All forward-looking statements contained in this release are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were made, and the company does not intend to update or otherwise revise the forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required by law.     Unaudited Consolidated Statement of Comprehensive Income
(Figures in million of U.S. dollars)    Continuing operations Three-month period ended 03/31/2026 Three-month period ended 03/31/2025 Revenues from contracts with customers 38.2 50.1 Initial recognition and changes in the fair value of biological assets at the point of harvest 1.2 1.0 Cost of sales (26.7) (33.0) Gross profit 12.7 18.1 % Gross profit 32% 35% Operating expenses (18.0) (21.3) Share of profit of JV 0.5 (0.9) Change in net realizable value of agricultural products (0.2) (0.2) Other income or expenses, net 0.7 8.8 Operating profit (4.3) 4.3 Financial result (9.7) (5.6) Profit/(loss) before income tax (14.1) (1.2) Income tax 4.0 3.6 Profit/(loss) for the period from continuing operations (10.0) 2.3       Discontinued operations     Loss for the period from discontinued operations - (3.9) Loss for the period from discontinued operations - (3.9)       Other comprehensive profit/loss 0.3 (0.8) Total comprehensive profit/(loss) (9.7) (2.4)       Profit/(loss) for the period of continuing operations attributable to     Equity holders of the parent (9.0) 2.6 Non-controlling interests (1.1) (0.3)   (10.0) 2.3     Weighted average number of shares     Basic 63.6 62.8 Diluted 63.6 62.8         Unaudited Consolidated Statement of Financial Position
(Figures in million of U.S. dollars)        ASSETS 31/03/2026   30/06/2025 CURRENT ASSETS       Cash and cash equivalents 14.4   32.7 Other financial assets 0.5   2.0 Trade receivables 136.3   165.9 Other receivables 13.0   15.9 Recoverable income tax 1.4   1.9 Inventories 48.4   87.6 Biological assets 4.4   2.4 Assets subject to foreclosure 42.4   - Total current assets 260.7   308.3 NON-CURRENT ASSETS       Other financial assets 0.0   0.0 Trade receivables 4.8   2.5 Other receivables 25.7   23.7 Recoverable income tax 0.0   0.0 Deferred tax assets 6.5   4.9 Investments in joint ventures and associates 40.6   39.4 Investment properties -   0.6 Property, plant and equipment 60.0   74.6 Intangible assets 83.9   181.2 Goodwill 36.1   112.2 Right of use asset 11.4   16.4 Total non-current assets 268.9   455.3 Total assets 529.6   763.6   LIABILITIES 31/03/2026   30/06/2025 CURRENT LIABILITIES       Trade and other payables 79.6   96.4 Borrowings 66.4   119.7 Employee benefits and social security 3.6   6.2 Deferred revenue and advances from customers 2.8   4.3 Income tax payable 4.8   0.5 Consideration for acquisition 2.1   1.8 Secured notes 108.3   102.3 Lease liabilities 2.6   6.9 Liabilities subject to foreclosure 27.4   - Total current liabilities 297.5   338.0 NON-CURRENT LIABILITIES       Trade and other payables 46.2   48.5 Borrowings 54.1   38.2 Deferred revenue and advances from customers 1.4   1.4 Joint ventures and associates 0.7   1.0 Deferred tax liabilities 24.3   30.1 Provisions 1.0   1.3 Consideration for acquisition 0.0   0.4 Secured notes -   - Lease liabilities 8.6   9.5 Total non-current liabilities 136.4   130.4 Total liabilities 433.9   468.4 EQUITY       Equity attributable to owners of the parent 67.7   265.4 Non-controlling interest 27.9   29.8 Total equity 95.7   295.2 Total equity and liabilities 529.6   763.6       View source version on businesswire.com: https://www.businesswire.com/news/home/20260511356435/en/ Bioceres Crop Solutions Paula Savanti
Head of Investor Relations
investorrelations@biocerescrops.com Original: Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results

CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern TimeMay 5, 2026 12:05 AM
Business Wire The dial-in details of release dated May 4, 2026 have been revised. The US Toll Free dial-in number should read 1-833-461-5787; the International dial-in numbers link has been updated; and the Conference ID: should read 717574163. The updated release reads: BIOCERES CROP SOLUTIONS TO HOST FISCAL THIRD QUARTER 2026 FINANCIAL RESULTS CONFERENCE CALL ON TUESDAY, MAY 12, 2026 AT 8:30 A.M. EASTERN TIME Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time to discuss its results for the fiscal third quarter ended March 31, 2026. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco, Chief Financial Officer Ezequiel Simmermacher, and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the company’s website here. To access the call, please use the following information: Date: Tuesday, May 12, 2026 Time: 8:30 a.m. ET, 5:30 a.m. PT US Toll Free dial-in number: 1-833-461-5787 International dial-in numbers: Click here Conference ID: 717574163 Webcast: Click here Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. The conference call will be broadcast live and available for replay here and via the investor relations section of the company’s website here. About Bioceres Crop Solutions Corp. Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. For more information, visit here. View source version on businesswire.com: https://www.businesswire.com/news/home/20260504715134/en/ Investor Relations Contact
Paula Savanti
Head of Investor Relations
investorrelations@biocerescrops.com Original: CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

Bioceres records $179 million impairment after foreclosure of Pro Farm assetsMarch 16, 2026 10:21 AM
IH Market News
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) reported a $179 million impairment charge after its Pro Farm assets were foreclosed and sold at auction for $15 million on January 20, 2026. The assets had previously been carried on the company’s books at roughly $194 million.The Argentina-based agricultural technology firm also disclosed in its fiscal second-quarter 2026 filing, covering the six months ended December 31, 2025, that there is substantial doubt about its ability to continue as a going concern. Chief Executive Officer Federico Trucco said the company is pursuing legal action related to the foreclosure process while continuing negotiations with noteholders regarding a potential transition arrangement.The Pro Farm operations—mainly located in the United States and Europe—have now been classified as discontinued operations. Bioceres noted that the foreclosure process has not yet been fully finalized, and the company has not determined the remaining debt balance after accounting for the $15 million auction proceeds.For its ongoing businesses, Bioceres reported consolidated gross margins of 40% year-to-date across its crop protection, crop nutrition and seed divisions, matching levels recorded in the previous year. The company cited difficult market conditions, including weaker commodity prices and tighter credit, which have affected the financial position of farmers in Argentina.Bioceres said it is currently in talks with Argentine financial institutions to refinance outstanding obligations and is also evaluating potential asset sales. In February 2026, its subsidiary Rizobacter Argentina S.A. successfully refinanced its Series VIII Class B corporate bonds, extending their maturity.During the second quarter of fiscal 2026, Bioceres also added two independent directors to its board. The board has instructed management to prepare a three-year financial plan for the remaining business, excluding the Pro Farm assets, with a focus on improving profitability and strengthening cash flow.The information was disclosed in a company press release accompanying its Form 6-K filing.Bioceres Crop Solutions stock price

Original: Bioceres records $179 million impairment after foreclosure of Pro Farm assets

BIOX..................................https://stockcharts.com/sc3/ui/?s=BIOX&p=w&b=5&g=0&id=p86431144783

$BCRS: Soaring to $5................. mega move

https://investors.biocerescrops.com/home/default.aspx


They been giving this a $8 target........... beaten down chart trying to show some life

https://s26.q4cdn.com/783252186/files/doc_presentations/2024/Nov/30/Bioceres-Crop-Solutions.pdf


GO $BIOX